Advertisement

Topics

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA Pipeline Review, H1 2019 [Report Updated: 29032019] Prices from USD $3500

22:32 EDT 13 Jun 2019 | BioPortfolio Report Blog

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA Pipeline Review, H1 2019


Summary


According to the recently published report 'Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha Pipeline Review, H1 2019'; Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA pipeline Target constitutes close to 11 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes.


Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA Granulocyte macrophage colony stimulating factor receptor subunit alpha also known as CD116 is a receptor for granulocyte macrophage colonystimulating factor. It is a member of the cytokine family of receptors. It plays an important role in controls the production, differentiation, and function of granulocytes and macrophages.


The report 'Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha Pipeline Review, H1 2019' outlays comprehensive information on the Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type; that are being developed by Companies / Universities.


It also reviews key players involved in Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are 2, 2, 1 and 4 respectively. Similarly, the universities portfolio in Phase I and Preclinical stages comprises 1 and 1 molecules, respectively.


Report covers products from therapy areas Oncology, Central Nervous System, Respiratory, Infectious Disease, Toxicology, Dermatology, Gastrointestinal and Hematological Disorders which include indications Melanoma, Alzheimer's Disease, Lung Disease, Metastatic Hormone Refractory Castration Resistant, AndrogenIndependent Prostate Cancer, Radiation Toxicity Radiation Sickness, Acute Radiation Syndrome, Acute Respiratory Distress Syndrome, Appendicitis, Chemotherapy Effects, Chemotherapy Induced Neutropenia, Crohn's Disease Regional Enteritis, Epithelial Ovarian Cancer, Lung Infections, Lung Injury, Malignant Pleural Mesothelioma, Metastatic Colorectal Cancer, Mild Cognitive Impairment, Mycobacterium Infections, Neurology, Peritoneal Cancer, Peritonitis, Radiation Injury, Respiratory Syncytial Virus RSV Infections, Skin Ulcers and Wounds.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The report provides a snapshot of the global therapeutic landscape for Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA

The report reviews Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources

The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities

The report reviews key players involved in Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA targeted therapeutics and enlists all their major and minor projects

The report assesses Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA targeted therapeutics


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA development landscape

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Original Article: Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA Pipeline Review, H1 2019 [Report Updated: 29032019] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha CDw116 or CD116 or CSF2RA Pipeline Review, H1 2019 [Report Updated: 29032019] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cytokine
Cytokines include chemokines, lymphokines, and monokines. Cells of the immune system communicate with one another by releasing and responding to chemical messengers called cytokines. These proteins are secreted by immune cells and act on other cells to...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...